Institute of Science Tokyo is accelerating collaboration between medical, dental, and engineering researchers following the ...

Lehi, Utah, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Lehi, Utah, January 27, 2026 – CancerVax, Inc., the developer of a breakthrough universal cancer treatment platform that uses the body’s immune system to ...

CLEVELAND, Ohio – Now, Wayne Dawson can talk about it without his voice cracking. Now, when he looks in the mirror, he ...

Researchers at the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute for Cancer Immunotherapy found that ...

For many cancer patients, hair loss is one of the most distressing side effects of their therapy. Increasingly, they have ...

In a landmark initiative inaugurated by the Honourable Chief Minister of Gujarat Shri Bhupendra Patel, Jenburkt Pharmaceuticals Limited has conceptualized and donated the Jenburkt ASHA Van India's ...

At Cancer Council WA, we're calling on the community to support life-saving local cancer research by donating to our annual Cancer Research Giving Day ...

Genetic mutations, oxidative stress, smoking, oral bacteria, and age-related blood mutations have been identified as early ...

PMI urges US FDA Advisory Committee to recommend authorizing ZYN as a modified risk tobacco product: Stamford, Connecticut Tuesday, January 27, 2026, 11:00 Hrs [IST] Experts from ...

Last January, the FDA authorized Zyn to remain on the market after years of federal review, saying company data showed the ...

Konstantinopoulos, M.D., Ph.D., Dana-Farber Cancer Institute, will highlight company’s recent interim clinical data from the ongoing, registrational-intent Phase 2b study of ACR-368 in subjects with e ...

A national clinical trial led by the Alliance for Clinical Trials in Oncology has found that abemaciclib, an oral cancer drug, may slow tumor growth in patients with aggressive meningiomas that have ...